Androgen deprivation for minimal metastatic disease: Threshold for achieving undetectable prostate-specific antigen Academic Article uri icon

Overview

MeSH Major

  • Androgen Antagonists
  • Antineoplastic Agents, Hormonal
  • Prostate-Specific Antigen
  • Prostatic Neoplasms

abstract

  • The probability of achieving an undetectable PSA level varied inversely with the disease extent. Although achieving an undetectable PSA level does not mean that a patient has been cured, it does establish an endpoint that can be used to identify approaches worthy of study in the Phase III setting.

publication date

  • May 2005

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1016/j.urology.2004.12.012

PubMed ID

  • 15882729

Additional Document Info

start page

  • 947

end page

  • 52

volume

  • 65

number

  • 5